By Professor Nadine Ezard

Conference Papers

Bonevski B; Rich JL; Jones M; Skelton E; Garfield JBB; Baker AL; Segan C; Gartner C; Walker N; Borland R; Daglish MRC; Dunlop AJ; Oldmeadow C; Bauld L; Bullen C; Ezard N; McGrohan R; Jacka D; White S; Lubman DI; Manning V, 2022, 'Baseline findings from project neat: Nicotine as treatment for tobacco smoking', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S33 - S34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700059&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Austin E; Jackson MA; Ismay C; Haber PS; Rodgers C; Ho T; Hallinan R; Lintzeris N; Oldmeadow C; Ezard N; Gartner C; Bonevski B; Dunlop AJ, 2022, 'Can e-cigarettes assist opiate agonist treatment clients to quit smoking? Preliminary results from HARMONY, a multi-site, single-blinded randomised controlled trial of e-cigarettes and nicotine replacement therapy', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S26 - S27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Black E; Mammen K; Deacon RM; Mills L; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Clients entering New South Wales alcohol and other drug treatment services: Characteristics by principal drug of concern, July 2016-June 2019', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S31 - S32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jacob J; Freeman G; Stefani M; Rodgers C; Ezard N, 2022, 'Interactions between methadone and rifampicin: A case series', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S78 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700135&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jackson MA; Austin EK; Lintzeris N; Ezard N; Gartner C; Oldmeadow C; Searles A; Nean M; Harrod ME; Mclennan J; Haber PS; Gill A; Graham R; Ho T; Hallinan R; Dunlop AJ; Bonevski B, 2021, 'CAN E-CIGARETTES ASSIST OPIATE AGONIST TREATMENT CLIENTS TO QUIT SMOKING? METHODS AND RECRUITMENT DATA', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S83 - S83, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ezard N; Dunlop AJ; Liaw W; Mcdonough M; Ali R; White J; Mcketin R; Bruno R; Carr A; Gill A; Rodgers C; Montebello M; Farrell M; Heinzerling K; Haber PS; Lubman DI; Graham R; Lintzeris N, 2021, 'COVID AND THE LIMA STUDY, A RANDOMISED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S12 - S13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dunlop AJ; White B; Roberts J; Graham R; Ezard N; Mcentyre LME; Doyle M; Kypri K; Lintzeris N; Haber PS, 2021, 'UNDERSTANDING HOW LONG-ACTING DEPOT BUPRENORPHINE IMPACTS THE HIGH-RISK POST-RELEASE PERIOD-PROTOCOL FOR THE RELEASE STUDY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S69 - S69, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200172&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Heijstee N; Black E; Black E; Demirkol A; Mills L; Deacon RM; Mammen K; Dunlop AJ; Ezard N; Montebello M; Reid D; Childs S; Lintzeris N, 2021, 'WHO WE ARE HELPING: DESCRIBING DEMOGRAPHIC, HEALTH AND SOCIAL FACTORS ASSOCIATED WITH PRINCIPAL DRUG OF CONCERN, ALCOHOL USE AND ALCOHOL-RELATED HARMS, IN THE AUSTRALIAN ALCOHOL AND OTHER DRUG TREATMENT-SEEKING POPULATION', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S79 - S79, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000715073200197&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lamoury F; Bajis S; Hajarizadeh B; Marshall A; Martinello M; Ivanova E; Catlett B; Mowat Y; Marks P; Amin J; Smith J; Ezard N; Cock V; Hayllar J; Persing D; Kleman M; Cunningham P; Dore G; Applegate T; Grebely J, 2018, 'Evaluation of the Xpert fingerstick HCV viral load assay', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S167 - S167, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30546-4

Grebely J; Lamoury F; Hajarizadeh B; Mowat Y; Marshall A; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore G; Applegate TL, 2017, 'Field evaluation of Xpert (R) HCV Viral Load point-of-care test for detection of hepatitis C virus infection by venipuncture-collected and finger-stick capillary whole-blood samples', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, NETHERLANDS, Amsterdam, pp. S709 - S709, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, NETHERLANDS, Amsterdam, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)31900-1

Conference Posters

Fletcher K; Ezard N; Siefried K; MacDonald H; Acheson L; Bedi G; Guerin A; Knock E; Millard M; May R; Brett J; Doumany J; Morgan C; Clifford B, 2024, 'An open-label safety and feasibility pilot trial of ketamine-assisted psychotherapy for methamphetamine use disorder', Canberra, Australia, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Siefried K; Acheson L; Dunlop A; Lintzeris N; Christmass M; Bonomo Y; Arunogiri S; Hayllar J; Ezard N, 2021, 'A clinical research network approach to a trial of lisdexamfetamine for the treatment of acute methamphetamine withdrawal', Virtual, Vol. 40, pp. S132 - S133, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Ezard N; Christmass M; Hayllar J; Ali R, 2021, 'Towards an Australian clinical research network for methamphetamine and emerging drugs - outcomes of the National Centre for Clinical Research on Emerging Drugs Methamphetamine and Emerging Drugs Clinical Research Network Working Group', Virtual, Vol. 40, pp. S133 - S134, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Acheson L; Williams BHM; Farrell M; McKetin R; Ezard N; Siefried K, 2021, 'Pharmacological treatment for methamphetamine withdrawal: a systematic review and meta-analysis of randomised controlled trials', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Black E; Deacon RM; Mills L; Mammen K; Dunlop A; Ezard N; Montebello M; Bruno R; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried K; Cretikos M; Lintzeris N, 2021, 'Starting treatment in public drug and alcohol services in New South Wales: What can electronic medical records tell us about amphetamine type stimulant use?', Virtual, presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

May R; Ezard N; Siefried K; Bruno R, 2021, 'Neurocognitive changes in adults with methamphetamine dependence treated with lisdexamfetamine compared with those with additional positive screening for childhood ADHD', presented at International Medicine in Addiction Conference, 26 February 2021 - 28 February 2021

Bolton A; Spooner C; Harris M; Ezard N, 2019, '"Ice" in general practice. Barriers & enablers to care in GP for people who regularly use methamphetamine: a protocol for a qualitative study (Poster)', Adelaide, presented at Australian Association for Academic Primary Care (AAAPC), 12 July 2019

Ezard N; Dunlop AJ; Clifford B; Bruno R; Siefried KJ; Carr A; Lintzeris N, 2019, 'Safety of oral lisdexamfetamine in adults with methamphetamine dependence: a dose-escalating phase-2 study', San Antonio, Texas, USA, presented at The College on Problems of Drug Dependence 81st Annual Scientific Meeting, San Antonio, Texas, USA, 15 June 2019 - 19 July 2019

Ezard N; Siefried KJ; Peacock A, 2019, 'Developing a national prompt response network for Australia', Amsterdam, The Netherlands, presented at The 11th International Conference on Nightlife, Substance Use and Related Health Issues, Amsterdam, The Netherlands, 15 May 2019 - 17 May 2019

Siefried KJ; Peacock A; Ezard N, 2019, 'Towards a prompt response network for Australia: coordinated and rapid communication of information about events of concerns related to emerging substances', Maastricht, The Netherlands, presented at Sixth International Conference on Novel Psychoactive Substances, Maastricht, The Netherlands, 08 April 2019 - 09 April 2019

Bolton A; Spooner C; Ezard N; Harris M, 2019, 'Caring for methamphetamine users in General Practice: interim results', Adelaide, presented at GP19, Adelaide

Conference Presentations

Acheson L; Ezard N; Fletcher K; Clifford B; Steele M; Moses M; Siefried K, 2024, 'A heuristic for evaluating methamphetamine withdrawal treatment programs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Freestone J; Xiao BJ; Siefried K; Bourne A; Ezard N; Maher L; Stirling R; Degenhardt L; Varma R; Hammoud M, 2024, 'Exploring service experiences among gay and bisexual men seeking to reduce or abstain from chemsex', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Broadbent E; Siefried K; Ezard N; MacDonald H; Gobeil J; Clifford B, 2024, 'Implementing a national Prompt Response Network to improve health-led decision making and processes for emerging drugs', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Knock E; Ezard N; Day R; Siefried K; Liknaitzky P; Ross M; Albert S; Brett J, 2024, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: A novel safety and feasibility trial', presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference 2024, Canberra, Australia, 30 October 2024 - 02 November 2024, http://dx.doi.org/10.1111/dar.13943

Siefried K; Clifford B; Acheson L; Ezard N, 2023, 'Innovations beyond BC: Lisdexamfetamine for the treatment of methamphetamine use disorder and withdrawal', presented at The 5th Annual BC Substance Use Conference, Vancouver, Canada, 20 April 2023 - 23 April 2023

Hill P; Clifford B; Brown J; Dessauer P; Oh G; Lyons T; Herbert A; McKinnon G; Lamb M; Crawford S; Mason C; Siefried K; Ezard N, 2023, 'Strength in solidarity: Bringing together diverse local stakeholders to disseminate public drug information (presented on behalf of the Prompt Response Network)', presented at Harm Reduction International, Melbourne, Australia, 16 April 2023 - 19 April 2023, https://hr23.hri.global/programme/

Ezard N; Clifford B; Siefried K; Acheson L, 2022, 'Safety and tolerability of lisdexamfetamine for  methamphetamine dependence and withdrawal, early experience from Australia: The LiMA Trial and OLAM pilot', presented at Annual Meeting Conference of the Norwegian Association for Addiction Medicine, Bergen, Norway, 02 November 2022

Siefried K; McKetin R; Bedi G; Brett J; Arunogiri S; Dunlop A; Lintzeris N; Ezard N, 2021, 'Symposium: An update on pharmacotherapy trials for substance use disorder - methamphetamine type and withdrawal in Australia', presented at The APSAD Scientific Drug and Alcohol Conference, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Arunogiri S; Brett J; McKetin R; Acheson LS; Knock E; Farrell M; Dunlop A; Lintzeris N; Ezard N, 2021, 'The future of pharmacotherapy clinical trials in Australia: the OLAM trial; the MOXY trial; the PSIMA trial; the TINA trial', presented at The APSAD Scientific Drug and Alcohol Conference, Virtual, 07 November 2021 - 10 November 2021, http://dx.doi.org/10.1111/dar.13384

Siefried K; Nguyen Q; Ezard N, 2019, 'An Australian clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern', presented at Lisbon Addictions 2019: The Third European Conference on Addictive Behaviours and Dependencies, Lisbon, Portugal, 23 October 2019 - 25 October 2019

Ezard N; Acheson LS; Siefried KJ; Leicester OM; Rodgers C; Malone V; Clifford B; Bruno R, 2019, 'Substance use sex index (SUSI): A new behaviour change assessment tool', presented at Lisbon Addictions 2019: The Third European Conference on Addictive Behaviours and Dependencies, Lisbon, Portugal, 23 October 2019 - 25 October 2019

Leung S; Deacon R; Rivas G; Monds L; Cubitt T; Nielsen S; Larance B; Ezard N; Lintzeris N, 2014, 'CHANGES IN ALPRAZOLAM USE AND RELATED HARM AMONG OPIOID TREATMENT PROGRAM CLIENTS FOLLOWING ITS RESCHEDULING TO A SCHEDULE 8 MEDICATION'

Lucas C; Ezard N; Day R, 2013, 'SYNTHETIC CANNABINOID USE: THE IMPORTANCE OF SURVEILLANCE', https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400152&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Moller C; Siefried K; Clifford B; Acheson L; Brett J; Dunlop A; Haber P; Christmass M; Lintzeris N; Morley K; Shoptaw S; Trivedi M; Ezard N, 2023, 'Oral naltrexone-bupropion combination pharmacotherapy for methamphetamine use disorder: Pilot study protocol', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749

Acheson L; McKetin R; Ezard N; Lintzeris N; Brett J; Rodgers C; Christmass M; Gill A; Farrell M; Dunlop A; Shoptaw S; Siefried K, 2023, 'Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749

Knock E; Ezard N; Day R; Siefried K; Liknaitzky P; Ross M; Albert S; Brett J, 2023, 'Psilocybin-assisted psychotherapy for methamphetamine use disorder: Recruitment to a novel safety and feasibility trial', in Drug and Alcohol Review, Wiley, Adelaide, Australia, Vol. 42, presented at The Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Adelaide, Australia, 12 November 2023 - 15 November 2023, http://dx.doi.org/10.1111/dar.13749

Freestone J; Ezard N; Brett J; Roberts DM; Murray J; Prestage G; Hammoud M; Siefried KJ, 2022, '"Sometimes I have a duty of care not to call 000": Reported practices, attitudes and factors influencing consumer responses to GHB overdose', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S64 - S64, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Knock E; Ezard N; Day R; Siefried KJ; Liknaitzky P; Ross M; Albert S; Brett J, 2022, 'A study protocol for the PsiMA trial: Psilocybin assisted psychotherapy for methamphetamine use disorder', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S82 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700142&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hill PL; Siefried KJ; Tzanetis S; Peacock A; Lenton S; Ezard N, 2022, 'An Australian national Prompt Response Network for emerging drugs', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S73 - S73, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700127&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Acheson LS; Gordon C; Ezard N; Lintzeris N; Dunlop AJ; Brett J; Rodgers C; Gill A; Christmass M; McKetin R; Farrell M; Shoptaw S; Siefried KJ, 2022, 'An exploratory analysis of actigraphy and sleep diaries in a methamphetamine withdrawal clinical trial', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S23 - S24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700042&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Peacock A; Bruno R; Barratt MJ; Ezard N; Hill PL; Harrod ME; Brown JA; Page R; Keygan J; Sumnall H; Sutherland R, 2022, 'Awareness of, and behavioural responses to, drug alerts in Australia: Findings from the Ecstasy and Related Drugs Reporting System and the Illicit Drug Reporting System', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S108 - S108, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700185&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Reilly R; Ramp J; Morton C; McKetin R; Butt J; Ezard N; Dunlop AJ; Conigrave KM; Quinn B; Treloar C; Gray D; Sivak L; Lockton J; Whetham H; Ward J, 2022, 'Lessons from the evaluation of a novel web-app to assist Aboriginal and Torres Strait Islander people to reduce or stop using methamphetamine: We can do this', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S117 - S118, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700202&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mills L; Mammen K; Deacon RM; Black E; Montebello M; Bruno R; Dunlop AJ; Ezard N; Shakeshaft A; Farrell M; Holmes J; Reid D; Childs S; Siefried KJ; Lintzeris N, 2022, 'Outcomes for clients in opioid treatment programs who use amphetamine type substances: Results from a retrospective analysis of routinely-collected clinical data', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S96 - S97, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700167&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bascombe F; Siefried KJ; Ezard N, 2022, 'Strengthening first-line support for Australians who use drugs, their friends and families: A training needs analysis for alcohol and other drug helplines for calls relating to methamphetamine and emerging drugs of concern', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S27 - S28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Clifford B; Shine P; Lo N; Stockwell T; Haber PS; Baldry E; Day CA; Dobbins T; Peacock A; Pauly B; Lintzeris N; Dolan K; Macklin B; Siefried KJ; Brett J; Dunlop AJ; Ezard N, 2022, 'The AusMAP study: A protocol for a randomised, controlled feasibility study of a managed alcohol program in Australia', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 41, pp. S44 - S45, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000862018700078&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Williams BH; Acheson LS; Farrell M; McKetin R; Ezard N; Siefried KJ; Farrell M, 2022, 'PHARMACOLOGICAL TREATMENT FOR METHAMPHETAMINE WITHDRAWAL: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 56, pp. 208 - 209

Siefried KJ; Nguyen QA; Ezard N; Christmass M; Ali R, 2019, 'A rapid clinical research priority setting study for substance use disorder due to methamphetamine and emerging drugs of concern in Australia', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Sandra S; Demerikol A; Branezac M; Ezard N; Siefried KJ; Acheson LS; Bascombe F; Tremonti C; Haber P; Lintzeris N, 2019, 'Are we detoxing the right people, in the right setting and in the right way? A rapid review of the literature on withdrawal management', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Black E; Deacon RM; Mills L; Dunlop A; Ezard N; Bruno R; Shakeshaft A; Farrell M; Holmes J; Cretikos MA; Montebello M; Reid D; Childs S; Siefried KJ; Mammen K; Lintzeris N, 2019, 'Characteristics and treatment outcomes of the drug treatment population in New South Wales: Focus on amphetamine type stimulants', in Drug and Alcohol Review, Wiley, Hobart, Australia, Vol. 38, presented at Australasian Professional Society on Alcohol and other Drugs (APSAD) Scientific Conference, Hobart, Australia, 10 November 2019 - 13 November 2019, http://dx.doi.org/10.1111/dar.12991

Back to profile page